Applied StemCell, Inc., a global provider of gene editing and stem cell-based services, as well as a leader in molecular and cellular reference standard products for clinical diagnostics markets, is proud to receive certifications for two International Organization for Standardization (ISO) Quality Management Systems (QMS) on October 20, 2017, the ISO 9001:2015 and 13485:2016. The […]

SAN DIEGO — Organovo Holdings, Inc.(NASDAQ:ONVO) (“Organovo”) and Viscient Biosciences (“Viscient”) today announced a collaboration to develop a custom research platform for studying liver disease.  The partnership is expected to expand upon Organovo’s current service portfolio for compound screening in disease models, which aids the drug discovery work of the Company’s customers.  Viscient is targeting early discovery […]

SHANGHAI, China and CUPERTINO, Calif. — Cellular Biomedicine Group Inc. (NASDAQ: CBMG) (“CBMG” or the “Company”), a leading clinical-stage biopharmaceutical firm engaged in the development of immunotherapies for cancer and effective stem cell therapies for degenerative diseases, today announced the establishment of a strategic partnership with Thermo Fisher Scientific (China) Ltd. (Thermo Fisher) to build a […]

Fluicell AB is extremely pleased to announce the signing of a license agreement with Cellectricon AB, granting the exclusive right, inter alia , to sell the Dynaflow Resolve technology worldwide and to use the related IP rights. The Dynaflow Resolve system is considered by many, to be the premier secondary ion channel screening platform on the market, […]

New patents protect SigNature T molecular tagging technology and a multimode reader device enabling IT integrated instant authentication  STONY BROOK, N.Y. – Applied DNA Sciences, Inc. (“Applied DNA,” “the Company,” NASDAQ: APDN) is pleased to announce the issuance of U.S. Patent No. 9,790,538 (US 2014/0256881) entitled “Alkaline Activation for Immobilization of DNA Taggants” and a Notice of […]

Key appointments follow on Series A financing to support the commercialization and distribution of the world’s first precision genomics platform for high throughput single-cell DNA analysis SOUTH SAN FRANCISCO, Calif.—Mission Bio, Inc., a leader in single-cell analysis and precision genomics, today announced new additions to the senior management team as the company scales and commercializes […]

On November 02, 2017, Annoroad announced the completion of its latest round of financing (nearly $105 million). This round of investment has been co-led by GTJA Investment Group and Ping An Ventures, other investors like SBCVC, SAIF Partners China, etc. are also involved.   Annoroad is focusing on the industrialized application of new-generation genomics technology […]

TwistDx’s recently launched range of liquid format Recombinase Polymerase Amplification (RPA) kits are ideal for rapid testing applications and high throughput laboratory use. This isothermal DNA/RNA amplification technology represents a versatile solution for nucleic acid detection, offering the same specificity as PCR but much faster results – typically within three to 10 minutes. The newly […]

MENLO PARK, Calif. — Pacific Biosciences of California, Inc. (NASDAQ:PACB) announced today that Kathy Ordoñez has been named Chief Commercial Officer and Executive Vice President. Ms. Ordoñez brings more than thirty years of experience in the life sciences and diagnostics industries, with senior roles at Hoffmann-La Roche, Celera, Quest Diagnostics and RainDance Technologies.  At Roche, Kathy was responsible for […]